In an era of increasing environmental consciousness, the pharmaceutical industry finds itself at a critical juncture. With the implementation of the EU's Corporate Sustainability Reporting Directive in January 2024, large pharmaceutical organisations are facing growing pressure to enhance their sustainability reporting practices. Our latest white paper, "Benchmarking Scope 3 Emissions Reporting Across the Pharmaceutical Industry," offers an in-depth exploration of this timely topic. The paper discusses the growing emphasis on addressing Scope 3 emissions and the trend towards more comprehensive reporting and adoption of science-based targets. Here's a glimpse of what you'll discover in our comprehensive analysis: Key Sustainability Frameworks and Initiatives shaping the pharmaceutical sector's approach to sustainability Industry-Wide Challenges and complexities of Scope 3 emissions reporting Comprehensive analysis of Scope 3 emissions data from the top 25 pharmaceutical and biotech org

August 19, 2024 Ahead of the CPHI conference taking place in Milan 8-10 October, we take a look at 5 key trends that are shaping the CDMO (Contract Development and Manufacturing Organisation) industry in 2024, and the industry's response to evolving market demands, technological advancements, and lessons learned from recent global challenges. More pharmaceutical companies, both large and small, are outsourcing drug projects to CDMOs, from development through commercialisation. This trend is driven by supply chain concerns, financial considerations, and the need for specialised skills and increased capacity. 1. Transition towards Customer-Driven Manufacturing : CDMOs are shifting to a customer-centric model, prioritising customer needs throughout all aspects of the business. This involves designing facilities around the customer experience and facilitating direct communication between executives and customers. At Veratrak, we strive to deliver innovative software solutions that optimise

Explore our case study "Leveraging Final Mile Data to Derive Standardised Carbon Emissions Reporting Across Continents" to discover how Veratrak empowers healthcare and life sciences companies to monitor their transportation and warehousing carbon footprints using the innovative Scope 3 metrics module within the Hub Platform. Customer Profile Top 10 Global Pharma (U.S.) 50+ Warehouses Globally $50+bn revenue (2023) Background A leading US pharmaceutical organisation with a complex global supply chain and distribution network faced increasing pressure to comply with Scope 3 emissions reporting regulatory requirements. Transport and Logistics leadership within the firm sought to accurately calculate and report their carbon emissions while establishing a baseline for future emissions reduction efforts. The Challenge The client needed to consolidate Transportation and Warehousing data from their extensive partner network into a unified platform. Across their varied logistics network, the c

July 31, 2024 We are excited to announce our participation in the CPhI Europe 2024 conference, taking place from October 8 to 10, 2024, at the Fiera Milano in Milan, Italy. The trade show, dedicated to shaping the future of pharma, is recognised as the largest gathering in the pharmaceutical and biotech industry, attracting over 47,000 professionals from more than 150 countries. During the three-day conference, attendees will have the opportunity to engage with key players in the pharmaceutical sector, explore innovative solutions, and foster valuable partnerships. Join us in Milan to discover the benefits of our new Purchase Orders Management module, designed to streamline the procurement process. The PO Management module integrates seamlessly with contract services organisations' ERP systems, providing Life Sciences and Pharmaceutical customers with an easy-to-use interface to submit purchase orders. By centralising all order-related activities on a single platform, Veratrak's soluti

Veratrak, an award-winning provider of supply chain solutions, has launched its new Purchase Orders Management module, designed to streamline the procurement process. The PO Management module integrates seamlessly with contract services organisations' ERP systems, providing Life Sciences and Pharmaceutical customers with an easy-to-use interface to submit purchase orders. Designed with the standards and regulations of the pharma industry in mind, this module offers a comprehensive suite of features aimed at enhancing efficiency and streamlining the purchasing process. By centralising all order-related activities on a single platform, Veratrak's solution enables seamless collaboration between buyers and suppliers to provide a clearer view of upcoming inventory needs and supplier commitments. Key benefits of the new module include real-time visibility into order status, automated workflows, and integration capabilities with existing enterprise ERP systems. These features work in tandem t

June 26, 2024 In pharmaceutical manufacturing, efficient data integration is crucial for streamlining operations, enhancing productivity, and ensuring compliance. Business process mapping (BPM), also called business process modelling, is a powerful tool that can help supply chain professionals visualise and optimise their workflows, making data integration more manageable and effective. In this article, we look at how you can leverage BPM to simplify data integration in your pharmaceutical supply chain. What is Business process mapping? Process mapping is a technique commonly used for capturing how a business process works. A process map is often visualised in the form of a flow chart, which highlights every step, decision, and task involved in a process. They help organisations get a high-level overview of how every process works and identify improvement opportunities. 1. Define Clear Objectives Effective business process mapping can lead to increased clarity, reduced errors, improved